Low Reporting of Cointerventions in Recent Cardiovascular Clinical Trials: A Systematic Review.

Journal of the American Heart Association
Elisavet MoutzouriNicolas Rodondi

Abstract

Background A cointervention in a randomized clinical trial (RCT) is medical care given in addition to the tested intervention. If cointerventions are unbalanced between trial arms, the results may be biased. We hypothesized that cointerventions would be more adequately reported in RCTs without full blinding or at risk of bias. Methods and Results To describe the reporting of cointerventions and to evaluate the factors associated with their reporting, we did a systematic search of all RCTs evaluating pharmacological interventions on cardiovascular outcomes published in 5 high-impact journals. The reporting of cointerventions, blinding, and risk of bias were extracted and evaluated independently by 2 reviewers (E.M., L.A.). Cointerventions were inadequately reported in 87 of 123 RCTs (70.7%), with 56 (45.5%) providing no information on cointerventions and 31 (25.2%) providing only partial information. Of the RCTs, 52 (42.3%) had inadequate blinding of participants and/or personnel and 63 (51.2%) of the RCTs were judged at risk of bias. In univariable analysis, the reporting of cointerventions was not associated with blinding of participants and/or personnel (odds ratio [OR], 1.04; 95% CI, 0.47-2.27 for adequately versus inadequat...Continue Reading

References

Jun 14, 2002·Journal of Clinical Epidemiology·Ioannis A GiannakakisJohn P A Ioannidis
Feb 11, 2005·JAMA : the Journal of the American Medical Association·Gregory W AlbersUNKNOWN SPORTIF Executive Steering Committee for the SPORTIF V Investigators
Feb 2, 2006·Cerebrovascular Diseases·Hans-Christoph Diener, UNKNOWN Executive Steering Committee of the SPORTIFF III and V Investigators
Oct 25, 2006·Clinical Trials : Journal of the Society for Clinical Trials·Mette Thorlund Haahr, Asbjørn Hróbjartsson
Oct 28, 2009·Archives of Internal Medicine·Isabelle PitrouPhilippe Ravaud
Feb 26, 2011·Journal of Pharmacology & Pharmacotherapeutics·Kenneth F SchulzDavid Moher
Jul 8, 2011·The New England Journal of Medicine·C M O'ConnorR M Califf
Aug 13, 2011·Clinical Trials : Journal of the Society for Clinical Trials·David L Sackett
Oct 20, 2011·BMJ : British Medical Journal·Julian P T HigginsUNKNOWN Cochrane Statistical Methods Group
Aug 27, 2013·Journal of Clinical Epidemiology·Susanne UnverzagtFrank Peinemann
Jun 30, 2014·Journal of Clinical Epidemiology·Segun BelloAsbjørn Hróbjartsson
Jun 4, 2015·The New England Journal of Medicine·Christopher P CannonUNKNOWN IMPROVE-IT Investigators
Feb 18, 2016·The New England Journal of Medicine·Walter N KernanUNKNOWN IRIS Trial Investigators
Jun 2, 2016·The New England Journal of Medicine·Laura E BothwellDavid S Jones
Jun 9, 2016·JAMA : the Journal of the American Medical Association·JoAnn E MansonJames M Robins
Jun 9, 2016·The New England Journal of Medicine·Jackson T WrightDavid M Reboussin
Jun 22, 2016·PLoS Medicine·John P A Ioannidis
Sep 17, 2016·The New England Journal of Medicine·Steven P MarsoUNKNOWN SUSTAIN-6 Investigators
Oct 18, 2016·Epidemiology·Mohammad Ali MansourniaMiguel A Hernán
Mar 25, 2017·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·C Marijn HazelbagUNKNOWN HDF Pooling Project investigators
Oct 14, 2017·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Miguel Sousa-UvaUlf Landmesser
Aug 28, 2018·The New England Journal of Medicine·UNKNOWN SCOT-HEART InvestigatorsMichelle C Williams
Aug 31, 2018·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Miguel Sousa-UvaUNKNOWN ESC Scientific Document Group
Aug 30, 2019·BMJ : British Medical Journal·Jonathan A C SterneJulian P T Higgins

❮ Previous
Next ❯

Software Mentioned

Stata
SPORTIF
Cochrane Collaboration risk

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.